The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members’ work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
Home > WHF Global Roadmaps > Atrial Fibrillation
The World Heart Federation Roadmap for Non-Valvular Atrial Fibrillation identifies roadblocks and suggests potential solutions to improve cardiovascular health and help reach the target set out in the Sustainable Development Goals: achieve a 30% reduction in NCDs, including CVD, by 2030.
This WHF Roadmap has been written by twelve experts from around the world: Murphy A, Banerjee A, Breithardt G, Camm J, Commerford P, Freedman B, Gonzales Hermosillo J, Halperin J, Lau C, Perel P, Xavier D, Wood D, Jouven X, and Morillo C.
A Roadmap is a framework to identify roadblocks and suggest potential solutions on the road to 2030. Global Roadmaps have been developed by worldwide experts to detect the problems and offer solutions on specific topics impacting cardiovascular mortality.
This Roadmap was launched on 3rd October 2016 at the WHF Roadmap event in Geneva, Switzerland, and has been published in Global Heart.
WHF has developed this roadmap with experts and its members to help identify the roadblocks and solutions. Whilst AF is not represented by a specific 25by25 target, it is a significant problem, in that it is often undiagnosed, and as a result a huge contributor to CVD premature mortality.
Between 1990 and 2013, although the global prevalence rate of AF decreased slightly, the overall number of AF cases increased, according to the Global Burden of Disease Study (GBD) 2013. The morbidity burden associated with AF, as measured by disability-adjusted life years (DALYs), also increased. Estimates of prevalence of AF, and DALYs associated with AF, are likely to underestimate true burden due to the high prevalence of asymptomatic AF (8) AF is also associated with high costs incurred by individuals, health care systems and economies.
Whilst Atrial Fibrillation is not represented by a specific 25by25 target, it is a significant problem, in that it is often undiagnosed, and as a result a huge contributor to CVD premature mortality. WHF has used the roadmap framework to give countries an insight into how this issue can be tackled, with the emphasis being on local adaptation and implementation strategies.
Atrial Fibrillation (AF) is associated with increased risk of stroke and is found in one third of all ischemic strokes. It is under-diagnosed and for this reason poises a significant burden of risk and economic cost, which, could be managed and reduced if diagnosed more effectively. AF is the commonest clinically significant arrhythmia. Consequences of AF can include, increased mortality, increased risk and severity of stroke, increased risk of hospitalization, reduction in quality of life, reduction of exercise capacity and increased risk of heart failure.
Translating global frameworks into local action for better heart health
Assessing strengths and gaps in national CVD programmes and policies
World Heart Federation launches global Roadmap to tackle Atrial Fibrillation